Biotech was Zentek’s largest segment in fiscal 2025, bringing in $792.50K of $872.50K (91%).
| Segments [axis] | FY 2025 |
|---|---|
| Biotech | $792.50K |
| Ip Development | $80.00K |
| Total | $872.50K |
Zentek brought in $872.50K from its two segments in fiscal 2025, the year ended March 31, 2025. Biotech was the largest at $792.50K (90.8%), ahead of Ip Development at $80.00K (9.2%).
Zentek (ZTEKF) reports its revenue by segments [axis]. In fiscal 2025, Biotech was its largest segment, bringing in $792.50K (90.8% of the total), followed by Ip Development at $80.00K (9.2%).
Biotech was Zentek's largest segment in fiscal 2025, bringing in $792.50K, or 90.8% of the $872.50K total across its two segments.
Every figure comes from Zentek's annual financial filings, as reported. Each line keeps the name Zentek gives it, and years follow its fiscal calendar.
Zentek's revenue by segments [axis] goes back to fiscal 2025, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.